ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,297.10
      -0.21%
      US Tech 100
      18,078.00
      -0.21%
      Dow Jones
      39,869.38
      -0.10%
      Brent Oil
      83.255
      0.06%
      Bitcoin
      65,435.24
      0.30%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Zai Lab Ltd (ZLAB)

      7. Zai Lab Ltd (ZLAB) News

      ZLAB

      Zai Lab (ZLAB)

      Zai Lab Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ZLAB
      DateTimeSourceHeadlineSymbolCompany
      12:13PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology
      05/16/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZLABZai Lab Ltd
      05/16/20247:30AMBusiness WireZai Lab Announces Participation in May and June Investor ConferencesNASDAQ:ZLABZai Lab Ltd
      05/15/20244:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZLABZai Lab Ltd
      05/14/20241:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZLABZai Lab Ltd
      05/14/20247:30AMBusiness WireZai Lab Announces Acceptance of Supplemental Biologics License Application with Priority Review for Efgartigimod Alfa Injection (Subcutaneous Injection) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in ChinaNASDAQ:ZLABZai Lab Ltd
      05/12/20248:20PMBusiness WireZai Lab Announces Approval of AUGTYRO™ (repotrectinib) for Patients with ROS1-positive NSCLC by China’s NMPANASDAQ:ZLABZai Lab Ltd
      05/08/20244:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZLABZai Lab Ltd
      05/08/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZLABZai Lab Ltd
      05/08/20244:05PMBusiness WireZai Lab Announces First Quarter 2024 Financial Results and Recent Corporate UpdatesNASDAQ:ZLABZai Lab Ltd
      04/15/20247:30AMBusiness WireZai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024NASDAQ:ZLABZai Lab Ltd
      04/11/20247:30AMBusiness WireZai Lab Statement on Executive Management Team’s Agreement on Share ActivitiesNASDAQ:ZLABZai Lab Ltd
      04/02/20247:30AMBusiness WireZai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology ProgramsNASDAQ:ZLABZai Lab Ltd
      04/01/20247:30AMBusiness WireZai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...NASDAQ:ZLABZai Lab Ltd
      03/27/20249:29AMBusiness WireZai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung CancerNASDAQ:ZLABZai Lab Ltd
      03/13/20247:05PMBusiness WireZai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid TumorsNASDAQ:ZLABZai Lab Ltd
      03/06/20244:01PMBusiness WireZai Lab to Present Final Overall Survival (OS) Data from Phase 3 NORA Study of ZEJULA (niraparib) in Platinum-Sensitive Recurrent Ovarian Cancer (PSROC)NASDAQ:ZLABZai Lab Ltd
      03/06/20247:30AMBusiness WireZai Lab Announces Participation in March Investor ConferenceNASDAQ:ZLABZai Lab Ltd
      03/04/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZLABZai Lab Ltd
      02/27/20244:20PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ZLABZai Lab Ltd
      02/27/20244:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZLABZai Lab Ltd
      02/27/20244:05PMBusiness WireZai Lab Announces Full-Year 2023 Financial Results and Recent Corporate UpdatesNASDAQ:ZLABZai Lab Ltd
      02/08/20244:37PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZLABZai Lab Ltd
      01/25/20244:15PMBusiness WireZai Lab to Announce Full-Year 2023 Financial Results and Recent Corporate Updates on February 27, 2024NASDAQ:ZLABZai Lab Ltd
      01/10/20245:12PMBusiness WireZai Lab Announces The New England Journal of Medicine Publication Demonstrating Durable Clinical Activity of Repotrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLCNASDAQ:ZLABZai Lab Ltd
      01/03/20247:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZLABZai Lab Ltd
      01/03/20247:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZLABZai Lab Ltd
      01/03/20247:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZLABZai Lab Ltd
      01/03/20243:50PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZLABZai Lab Ltd
      01/03/20243:47PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZLABZai Lab Ltd
       Showing the most relevant articles for your search:NASDAQ:ZLAB

      Your Recent History

      NASDAQ
      MIBIX
      Delayed Upgrade Clock